Time to gender-affirming hormone therapy among US military-affiliated adolescents and young adults

Abstract: Importance: Use of exogenous sex steroid hormones, when indicated, may improve outcomes in adolescents and young adults with gender incongruence. Little is known about …

Gender-affirming hormone treatment and metabolic syndrome among transgender Veterans

Abstract: Importance: Gender-affirming hormone treatment (GAHT) is a common therapy for transgender individuals to reduce gender dysphoria and improve quality of life. Clarifying …

Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations

Abstract: Background: Gender-affirming hormone therapy (GAHT) is a common medical intervention sought by transgender and gender diverse (TGD) individuals. Initiating GAHT in …

Three cases of thyroid cancer in transgender female Veterans receiving gender-affirming estrogen treatment

Abstract: Background: Papillary thyroid cancers are relatively common endocrine malignancies. Risks include obesity, smoking, family history, and radiation exposure. Estrogens may …

Patient Characteristics Associated with Receiving Gender-Affirming Hormone Therapy in the Veterans Health Administration

Abstract: Purpose: This study aimed to examine patient characteristics associated with receipt of gender-affirming hormone therapy in the Veterans Health Administration (VHA). …

Thyroid Cancer Prevalence, Risk Exposure, and Clinical Features Among Transgender Female Veterans

Abstract: Purpose: Transgender women experience higher-than-average rates of multiple medical conditions. Thyroid cancer occurs more frequently in those assigned female at birth …

Barriers and facilitators to gender-affirming hormone therapy in the Veterans Health Administration

Abstract: BACKGROUND: In 2011, the Veterans Health Administration (VHA) established a policy for the delivery of transition-related services, including gender-affirming hormone …